Alan Verkman, MD, PhD
Professor
Division of Nephrology
University of California, San Francisco
513 Parnassus Avenue, HSE 1246
San Francisco, CA. 94143-0521
Phone: 415.476.8530
Fax: 415.665.3847
E-mail: alan.verkman@ucsf.edu
| College: |
M.I.T.
|
Medical School: |
Harvard Medical School
|
|
Other Graduate Training: |
Harvard University (A.M., Ph.D. physics)
|
Internal Medicine Residency: |
Brigham & Womens' Hospital
|
|
Nephrology Fellowship:
|
University of California, San Francisco
|
Interests
Research: Biology of water and chloride transport; aquaporins; cystic fibrosis research; novel optical methods applied to cells and in vivo; drug discovery; translational research
Scholarly and Creative Activities (selected)
Levin, M.H., R. de la Fuente and A.S. Verkman (2007). Urearetics: a small molecule screen yields nanomolar potency inhibitors of urea transporter UT-B. Faseb J. 21:551-563.
Haggie, P.M., J.K. Kim, G.L. Lukacs, and A.S. Verkman (2006). Tracking of quantum dot-labeled CFTR shows near immobilization at the plasma membrane by C-terminal PDZ interactions. Mol. Biol. Cell 17:4937-4945.
Thiagarajah, J.R., J.K. Kim, M. Magzoub, and A.S. Verkman (2006). Slowed diffusion in tumors revealed by microfiberoptic epifluorescence photobleaching. Nature Meth. 3:275-280.
Padmawar, P., X. Yao, O. Bloch, G.T. Manley and A.S. Verkman (2005). K+ waves in brain cortex visualized using a long-wavelength K+-sensing fluorescent indicator. Nature Meth. 2:825-827.
Saadoun, S., M.C. Papadopoulos, M. Hara-Chikuma and A.S. Verkman (2005). Impairment of angiogenesis and cell migration by targeted of aquaporin-1 gene disruption. Nature 434:786-792.
Pedemonte, N., G.L. Lukacs, K. Du, E. Caci, O. Zegarra-Moran, L.J. Galietta and A.S. Verkman (2005). Small molecule correctors of defective F508-CFTR cellular processing identified by high-throughput screening. J. Clin. Invest. 115:2564-2571.
For more publications: PubMed for Verkman, Alan
Lab
Link to Verkman Lab page http://www.ucsf.edu/verklab/
|
